Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Peter Goedegebuure

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Cancers|October 16, 2025
Long-Acting Recombinant IL-7 (rhIL-7-hyFc) Enhances the Primary and Memory Neoantigen-Specific Immune Response to Breast Cancer Personalized Cancer VaccinesMichael Chen, Thomas Kane, Ina Chen, et al.
Viruses|November 25, 2023
Engineering a Novel Modular Adenoviral mRNA Delivery Platform Based on Tag/Catcher BioconjugationKexin Geng, Paul J Rice-Boucher, Elena A Kashentseva, et al.
Lab on a Chip|November 6, 2018
Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoidsVenktesh S Shirure, Ye Bi, Matthew B Curtis, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 19, 2017
The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancerYassar M Hashim, Suwanna Vangveravong, Narendra V Sankpal, et al.
Plos Computational Biology|January 5, 2024
sc2MeNetDrug: A computational tool to uncover inter-cell signaling targets and identify relevant drugs based on single cell RNA-seq dataJiarui Feng, S Peter Goedegebuure, Amanda Zeng, et al.
Scientific Reports|May 5, 2016
Erratum: Membrane-proximal TRAIL species are incapable of inducing short circuit apoptosis signaling: Implications for drug development and basic cytokine biologyKatharina Tatzel, Lindsay Kuroki, Igor Dmitriev, et al.
Scientific Reports|March 4, 2016
Membrane-proximal TRAIL species are incapable of inducing short circuit apoptosis signaling: Implications for drug development and basic cytokine biologyKatharina Tatzel, Lindsay Kuroki, Igor Dmitriev, et al.
Scientific Reports|March 17, 2024
The novel drug candidate S2/IAPinh improves survival in models of pancreatic and ovarian cancerTakaomi Hagi, Suwanna Vangveravong, Rony Takchi, et al.
Journal of Ovarian Research|February 16, 2019
Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agentsRebeca González-Pastor, Ahmad Mohammad Ashshi, Adel Galal El-Shemi, et al.
Cancer Research|August 2, 2014
CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer modelsYu Zhu, Brett L Knolhoff, Melissa A Meyer, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Cancers|October 16, 2025
Long-Acting Recombinant IL-7 (rhIL-7-hyFc) Enhances the Primary and Memory Neoantigen-Specific Immune Response to Breast Cancer Personalized Cancer VaccinesMichael Chen, Thomas Kane, Ina Chen, et al.
Viruses|November 25, 2023
Engineering a Novel Modular Adenoviral mRNA Delivery Platform Based on Tag/Catcher BioconjugationKexin Geng, Paul J Rice-Boucher, Elena A Kashentseva, et al.
Lab on a Chip|November 6, 2018
Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoidsVenktesh S Shirure, Ye Bi, Matthew B Curtis, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 19, 2017
The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancerYassar M Hashim, Suwanna Vangveravong, Narendra V Sankpal, et al.
Plos Computational Biology|January 5, 2024
sc2MeNetDrug: A computational tool to uncover inter-cell signaling targets and identify relevant drugs based on single cell RNA-seq dataJiarui Feng, S Peter Goedegebuure, Amanda Zeng, et al.
Scientific Reports|May 5, 2016
Erratum: Membrane-proximal TRAIL species are incapable of inducing short circuit apoptosis signaling: Implications for drug development and basic cytokine biologyKatharina Tatzel, Lindsay Kuroki, Igor Dmitriev, et al.
Scientific Reports|March 4, 2016
Membrane-proximal TRAIL species are incapable of inducing short circuit apoptosis signaling: Implications for drug development and basic cytokine biologyKatharina Tatzel, Lindsay Kuroki, Igor Dmitriev, et al.
Scientific Reports|March 17, 2024
The novel drug candidate S2/IAPinh improves survival in models of pancreatic and ovarian cancerTakaomi Hagi, Suwanna Vangveravong, Rony Takchi, et al.
Journal of Ovarian Research|February 16, 2019
Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agentsRebeca González-Pastor, Ahmad Mohammad Ashshi, Adel Galal El-Shemi, et al.
Cancer Research|August 2, 2014
CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer modelsYu Zhu, Brett L Knolhoff, Melissa A Meyer, et al.
Pageof 6